Breast Milk vs. Formula and NEC: AAP Guidelines and the Donor Milk Alternative

What Human Breast Milk Provides That Formula Cannot

Human breast milk is not simply a source of calories and macronutrients — it is a living biological fluid containing hundreds of bioactive components that protect and mature the premature gut. These include secretory IgA (the primary immune antibody in mucosal defense), lactoferrin (an iron-binding protein with antimicrobial and anti-inflammatory properties), lysozyme (a bacterial cell wall enzyme), human milk oligosaccharides (HMOs, which selectively feed beneficial bacteria and block pathogen adherence), epidermal growth factor (EGF) and insulin-like growth factor (IGF-1) (which promote intestinal healing and maturation), and exosomes and microRNA that regulate gene expression in the neonatal gut epithelium. Cow's milk-based premature infant formula provides none of these elements. It replaces a biologically complex, protective fluid with a nutritionally adequate but immunologically inert product that actively promotes different bacterial communities than human milk.

The AAP Position on Donor Breast Milk

The American Academy of Pediatrics (AAP) Section on Breastfeeding issued policy statements in 2012 and again in 2022 explicitly recommending pasteurized donor human milk as the preferred alternative to mother's own milk for premature infants when mother's milk is unavailable or insufficient. The 2022 AAP policy statement states: 'When the mother's own milk is unavailable or insufficient, pasteurized donor human milk should be used for preterm or high-risk infants.' The World Health Organization similarly recommends pasteurized donor breast milk as the second choice after mother's own milk for premature and sick newborns. The Human Milk Banking Association of North America (HMBANA) operates a network of non-profit donor milk banks across the US that screen, pasteurize, and dispense donor milk to NICUs. Despite the availability of donor milk through HMBANA and for-profit sources like Prolacta Bioscience and Medolac, many NICUs defaulted to cow's milk-based formula for economic or logistical reasons, while Abbott and Mead Johnson continued to market their bovine formula products without prominent warnings about the NEC risk.

The Legal Significance of the Breast Milk Evidence

The AAP's recommendation of donor breast milk over cow's milk formula for premature infants is among the most important pieces of evidence in NEC formula litigation. It establishes that a safer alternative existed and was endorsed by the nation's leading pediatric medical authority. It demonstrates that Abbott and Mead Johnson were marketing their products in the face of a clear professional medical consensus recommending against cow's milk formula as the preferred nutritional source for premature infants. Plaintiffs' experts use this evidence to argue that the defendants' warnings — such as they were — failed to communicate the scientific consensus adequately to the neonatologists, hospital formulary committees, and parents who made feeding decisions for premature infants.